Postal Ballot- Scrutinizer''''s Report for Postal Ballot Notice dated April 02, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd got shareholder approval through a postal ballot to increase its authorized share capital and amend the Capital Clause of its Memorandum of Association. The e-voting window ran from March 2 to March 31, 2025, and the result was declared on April 2, 2025, with 112,150 shareholders on record as of February 28, 2025. The ordinary resolution passed with overwhelming support — 62,11,792 votes (99.12%) in favour and just 55,423 votes (0.88%) against, with no invalid votes. The promoter group declared no interest in the resolution, and Mr. Mehul Pitroda acted as the scrutinizer for the process. Note: The BSE headline tags this under Supha Pharmachem Ltd, but the actual filing is from Remedium Lifecare Ltd (Scrip Code: 539561).
The higher authorized capital ceiling gives the company flexibility to issue more shares in the future for fundraising, expansion, or acquisitions, though no immediate issuance is being approved. The near-unanimous approval signals strong shareholder backing for management's capital plans.